[FATE] YoY Annual Result on 31-Dec-2016 [#FY]

Stock
[FATE] Fate Therapeutics, Inc.
Announcement Date
16-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#FY]
Profit Trend
YoY- -11.57%
Quarter Report
FATE's Result
FATE's Financial Summary
View:
Show?
Annual Result
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
Revenue 10,680 4,740 4,106 4,402 2,431 0 971 49.10%
PBT -98,149 -66,598 -42,952 -33,462 -29,992 -25,883 -20,894 29.39%
Tax -441 2,190 297 -743 -677 53 796 -
NP -97,708 -66,598 -42,952 -33,462 -29,992 -25,883 -20,894 29.30%
Tax Rate - - - - - - - -
Total Cost 108,388 71,338 47,058 37,864 32,423 25,883 21,865 30.56%
Ratio Analysis
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
NP Margin -914.87 -1,405.02 -1,046.08 -760.15 -1,233.73 0.00 -2,151.80 -13.27%
Per Share
31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 31/12/13 CAGR
EPS -1.43 -1.19 -1.02 -1.05 -1.18 -1.27 -3.54 -14.01%
EPS Diluted -1.43 -1.19 -1.02 -1.05 -1.18 -1.27 -3.54 -14.01%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.